USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: O-RAY PHARMA, INC.
State: CA
Zip+4: 91107-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $154,472.00 1
SBIR Phase II $1,071,370.00 1

Award List:

Sustained Release Inner Ear Delivery of Corticosteroid

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: William H. Slattery
Award Amount: $1,071,370.00
DESCRIPTION (provided by applicant): Project Summary The broad long term goal of this research program is to reduce or eliminate deafness by developing sustained release intracochlear drug delivery systems. The goal of this project is to develop a ster oid eluting cochlear implant. Currently,… More

Ototoxicity protection with intratympanic steroid implant

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Erik Pierstorff – 626-844-1906
Award Amount: $154,472.00
DESCRIPTION (provided by applicant): Chemotherapy-induced ototoxicity is damage to the inner ear that is caused by the side effects of administered drugs. This can lead to permanent hearing loss and/or tinnitus (continuous ringing in the ear) in the patient. Some of the most common kinds of drugs… More